Clinical Trials Logo

Glaucoma, Neovascular clinical trials

View clinical trials related to Glaucoma, Neovascular.

Filter by:

NCT ID: NCT00491712 Active, not recruiting - Clinical trials for Neovascular Glaucoma

Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves With and Without Intravitreal Triamcinolone Injection

Start date: September 2005
Phase: N/A
Study type: Interventional

The management of neovascular glaucoma (NVG) is a challenge for the ophthalmologist and surgery is frequently needed to control IOP. The success rates of a drainage device is usually lower in NVG than in other forms of glaucoma. Triamcinolone intra-vitreous injections acetate has been used to treat macular edema secondary to diabetic retinopathy and central retinal vein occlusion and also to control inflammation in ophthalmologic surgeries. In the present study we will compare the outcome and complications of Silicone Ahmed Valve in GNV eyes with and without intra-vitreous triamcinolone injection.

NCT ID: NCT00441181 Withdrawn - Clinical trials for Neovascular Glaucoma

Effects of Travoprost on Neovascular Glaucoma

Start date: January 2008
Phase: N/A
Study type: Interventional

Prostaglandin analogues have not been used in the treatment of neovascular glaucoma because of suspicious lack of efficacy. This study aims at assessing the effect of travoprost on neovascular glaucoma.

NCT ID: NCT00384631 Completed - Glaucoma Clinical Trials

Intravitreal Bevacizumab for Neovascular Glaucoma

IVB NVG
Start date: April 2006
Phase: N/A
Study type: Interventional

Several studies have confirmed high levels of vascular endothelial growth factor (VEGF) in eyes with neovascular glaucoma (NVG). The role of VEGF inhibitors in regression of other neovascular disorders such as wet-type age-related macular degeneration and diabetic macular edema has been described. We aim to evaluate the effect of three intravitreal injections of bevacizumab (Avastin) 2.5 mg versus a sham procedure for treatment of NVG. Outcome measures include intraocular pressure and extent of iris neovascularization. Both study arms will receive conventional treatment for NVG.